We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
+29.88%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$2.78B
AUM Growth
+$40.3M
Cap. Flow
-$635M
Cap. Flow %
-22.8%
Top 10 Hldgs %
41.28%
Holding
156
New
21
Increased
23
Reduced
32
Closed
45

Sector Composition

Rank Sector Weight
1 Healthcare 52.44%
2 Financials 2.69%
3 Technology 0.73%
4 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MNK
126
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
-510,791
Closed -$46M
TTPH
127
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
-22,510
Closed -$8.98M
WCG
128
DELISTED
Wellcare Health Plans, Inc.
WCG
-15,000
Closed -$905K
WAGE
129
DELISTED
WageWorks, Inc.
WAGE
-190,770
Closed -$8.69M
KERX
130
PUT
DELISTED
Keryx Biopharmaceuticals Inc
KERX
-700,000
Closed -$9.63M
AET
131
DELISTED
Aetna Inc
AET
-169,194
Closed -$13.7M
AET
132
PUT
DELISTED
Aetna Inc
AET
-375,000
Closed -$30.4M
ELOS
133
DELISTED
Syneron Medical Ltd
ELOS
-13,893
Closed -$139K
WGBS
134
DELISTED
WaferGen Bio-systems, Inc.
WGBS
-91,040
Closed -$1.98M
TEAR
135
DELISTED
TearLab Corporation
TEAR
-35,410
Closed -$1.2M
XNPT
136
DELISTED
XENOPORT, INC.
XNPT
-4,438,882
Closed -$23.9M
POZN
137
DELISTED
POZEN INC
POZN
-816,254
Closed -$5.99M
CYBX
138
DELISTED
CYBERONICS INC
CYBX
-110,000
Closed -$5.63M
LPDX
139
DELISTED
LIPOSCIENCE INC COM
LPDX
-679,180
Closed -$3.52M
BIND
140
DELISTED
BIND THERAPEUTICS INC
BIND
-274,000
Closed -$2.35M
OSIR
141
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
-388,039
Closed -$4.88M

Similar funds

Deerfield Management's Q4 2014 Portfolio in Review

As of Q4 2014, Deerfield Management held 156 positions worth $2.78B, up 1.5% from $2.74B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Deerfield Management withdrew a net $635M in Q4 2014, closing 45 positions and reducing 32 holdings. Its most notable exit was MALLINCKRODT PUBLIC LIMITED COMPANY, an estimated $46M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 52% of assets, up from 47% a quarter earlier, followed by Financials and Technology.

Against the trend, Deerfield Management opened a new position in Achillion Pharmaceuticals worth $35.8M.

  • Deerfield Management's largest Q4 2014 buy was Achillion Pharmaceuticals: 2,920,300 shares worth $35.8M.
  • Deerfield Management added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2014, an estimated $77.3M increase.
  • Deerfield Management's biggest Q4 2014 reduction was Kite Pharma, Inc., cutting an estimated $36M.
  • Deerfield Management fully exited MALLINCKRODT PUBLIC LIMITED COMPANY in Q4 2014, selling an estimated $46M.
  • Deerfield Management's ten largest holdings make up 41% of its $2.78B portfolio in Q4 2014.
  • Deerfield Management opened 21 new positions and closed 45 in Q4 2014.
  • Deerfield Management's portfolio value rose 1.5% quarter-over-quarter to $2.78B.

Based on Deerfield Management's 13F filing for Q4 2014, filed 17 Feb 2015.